Online accredited continuing education (ACE) release date: June 1, 2022 SCCM Product Code: MCCRCP22 ACE expiration date: December 31, 2024 Estimated time for activity completion: 31 hours for online lectures, 8.75 hours for live study group, total: 39.75
Blended learning: self-directed and optional live in-person study groups.
The Society of Critical Care Medicine (SCCM) supports recommendations that will promote lifelong learning through continuing education. SCCM promotes activities that encourage the highest quality in education that will enhance knowledge, competence, or performance in critical care practice. This activity will meet the following competencies:
You can access pretest, course materials, and posttests; complete your evaluation; and claim your ACE credit by logging in to your MySCCM account with your SCCM Customer ID and password, then clicking on the icon for the course you are enrolled in under the MyLearning tab. If needed, you can click “Forgot my password” to reset your secure password.
For the online education portion of this course, a successful completion of this continuing medical education (CME) activity, which includes participation and a passing score of 70% (three attempts) on the posttest and completion of the overall evaluation, enables the participant to earn up to 39.75 credits hours.
Physicians: Accreditation Statement: The Society of Critical Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: The Society of Critical Care Medicine designates this enduring educational activity for a maximum of 39.75 AMA PRA Category 1 credit™. Physicians should claim only those hours of credit that they actually spent in the educational activity.
Nurses: The Multiprofessional Critical Care Review: Pediatric Smart Course activity has been approved by the California Board of Registered Nursing, Provider No. 8181, for up to 39.75 contact hours.
Pharmacists: The Society of Critical Care Medicine is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This enduring educational activity provides up to 39.75 contact hours of continuing education credit.
(For online education 0236-0000-22-130-H01-P, for live study session 0236-0000-22-130-L01-P)
SCCM reports to a continuing pharmacy education (CPE) tracking service, CPE Monitor, which will authenticate and store data for completed CPE units received by pharmacists and pharmacy technicians. The tracking system will make CPE data for each participant available to the state boards of pharmacy where the participant is licensed or registered. After CPE units are processed by ACPE and the National Association of Boards of Pharmacy (NABP), pharmacists and pharmacy technicians will be able to log in to a comprehensive electronic profile to access information about their completed CPE.
Physician Assistants: The American Academy of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 39.75 Category 1 credits for completing this activity.
Successful completion of this accredited continuing education (ACE) activity, which includes participation and a passing score of 70% in the evaluation component/posttest, enables the participant to earn up to 39.75 medical knowledge maintenance of certification (MOC) points in the American Board of Internal Medicine (ABIM), American Board of Surgery (ABS), American Board of Anesthesiology (ABA), and American Board of Pediatrics (ABP) MOC programs. Participants will earn MOC points equivalent to the amount of ACE credits claimed for the activity. It is the ACE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. ABS requires participants to self-report credit if audited.
This course meets the requirements for maintenance of certification (MOC) for up to 39.75 credits.
To provide due process in the evaluation and mediation of grievances concerning ACE activities, this Grievance Procedures Policy was developed. Grievances may concern, but are not limited to, the awarding of credit for individual participation and/or registration fees issues.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established conflict-of-interest resolution process and have stated that these reported relationships will not have any impact on their ability to provide unbiased content.
Planners: Ira M. Cheifetz, MD, FCCM Rainbow Babies and Children’s Hospital Cleveland, Ohio, USA Medtronic – medical advisor; Up-to-date - contributor
Ana Lia Graciano, MD, FCCM University of Maryland Baltimore, Maryland, USA No relevant financial relationships to disclose
Ravi Thiagarajan, MD Boston Children’s Hospital Boston, Massachusetts, USA Bristol Myers Squibb and Pfizer - member event adjudication committee for clinical trial
Theresa Woike Society of Critical Care Medicine Mount Prospect, Illinois, USA No relevant financial relationships to disclose
Faculty: Asya Agulnik, MD St. Jude Children’s Research Hospital Memphis, Tennessee, USA No relevant financial relationships to disclose
Alicia M. Alcamo, MD, MPH Children’s Hospital of Philadelphia Philadelphia, Pennsylvania, USA No relevant financial relationships to disclose
Raj Aneja, MD, FCCM Children’s Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, USA No relevant financial relationships to disclose
Edward E. Conway Jr, MD, MS, FCCM Jacobi Medical Center Bronx, New York, USA No relevant financial relationships to disclose
Dennis Daniel, MD Boston Children’s Hospital Milton, Massachusetts, USA No relevant financial relationships to disclose
Leslie Dervan, MD Seattle Children’s Hospital Seattle, Washington, USA No relevant financial relationships to disclose
Michael W. Dingeldein, MD Rainbow Babies and Children’s Hospital Cleveland, Ohio, USA No relevant financial relationships to disclose
Allan Doctor, MD University of Maryland Medical Center Baltimore, Maryland, USA Consulting – Viasys, iNO Therapeutics; Galera Pharmaceuticals, Nitrox~N30Pharma; Novartis, Biogen; Research Funding – NIGMS, NHLBI, DoD CDMRP, American Heart Association, Doris Due Foundation, Children’s Discovery Institute, Terumo, BCT and Entergion; Founder/Owner – KaloCyte, Inc
Nicholas A. Ettinger, MD, PhD, FAAP Texas Children’s Hospital Houston, Texas, USA No relevant financial relationships to disclose
Robinder G. Khemani, MD Children’s Hospital Los Angeles Los Angeles, California, USA Nihon Kohden Orangemed – medical advisor
Sapna R. Kudchadkar, MD, PhD Johns Hopkins University Hospital Baltimore, Maryland, USA No relevant financial relationships to disclose
Ryan W. Morgan, MD, MTR Children’s Hospital of Philadelphia Philadelphia, Pennsylvania, USA No relevant financial relationships to disclose
Jennifer Muszynski, MD, FCCM Nationwide Children’s Hospital Columbus, Ohio, USA No relevant financial relationships to disclose
Gideon Stitt, PharmD, BCPPS, BCCCP Children’s Hospital of Philadelphia Philadelphia, Pennsylvania, USA No relevant financial relationships to disclose
Katri V. Typpo, MD, MPH University of Arizona College of Medicine Tucson, Arizona, USA Leading Biosciences – consulting services
Henry Michael Ushay, MD, PhD, FCCM Children’s Hospital at Montefiore Bronx, New York, USA No relevant financial relationships to disclose
Scott L. Weiss, MD, MSCE, FCCM Children’s Hospital of Philadelphia Philadelphia, Pennsylvania, USA No relevant financial relationships to disclose
Janice L. Zimmerman, MD, MCCM Houston, Texas, USA No relevant financial relationships to disclose
Jerry J. Zimmerman, MD, PhD, FCCM Seattle Children’s Hospital Seattle, Washington, USA No relevant financial relationships to disclose